Infectious Disease

/Tag:Infectious Disease
28 07, 2015

July 28 is World Hepatitis Day

By |July 28th, 2015|Infectious Diseases, World Hepatitis Day|Comments Off on July 28 is World Hepatitis Day

According to the reports from the World Health Organization (WHO), 400 million people are living with hepatitis B and C worldwide, while 1.4 million die due to these infections every year. In 2010, WHO decided to observe July 28 every year as World Hepatitis Day. This particular date was chosen in honor of the birthday [...]

23 01, 2015

Roche Partnering with Meiji and Fedora to Battle Drug-resistant Bacterial Infections

By |January 23rd, 2015|Roche|Comments Off on Roche Partnering with Meiji and Fedora to Battle Drug-resistant Bacterial Infections

Roche, the world's largest biotech company and frontrunner in providing medicines in oncology, immunology, and infectious diseases has joined forces with Meiji Seika Pharma Co., Ltd. and Fedora Pharmaceuticals to fight increasing bacterial resistance to antibiotics. Under the agreement, Roche has obtained worldwide rights (except Japan) from both companies for development and commercialization of OP0595, [...]

22 12, 2014

Molecular Assays for Better Management of RTIs and Influenza

By |December 22nd, 2014|Infectious Diseases|Comments Off on Molecular Assays for Better Management of RTIs and Influenza

The holiday season is here and people need to remember that it is also the flu season. The Centers for Disease Prevention and Control estimates that, every year, influenza affects 5 percent to 10 percent of adults and 20 percent to 30 percent of children globally and causes about 3,000 and 49,000 deaths in the [...]

19 12, 2014

Top Featured News Stories 2014

By |December 19th, 2014|Laboratory Equipment, News|Comments Off on Top Featured News Stories 2014

2014 was a very eventful year globally for the clinical diagnostics industry. Milestones were set and new products and services launched. Deadly diseases such as Ebola struck and U.S. government agencies, the World Health Organization (WHO), and other domestic and international partners came together to battle the virus. We have put together some of the [...]

10 12, 2014

Immunoassays Expedite Clinical Decision-making

By |December 10th, 2014|Awareness Technology, Immunoassays|Comments Off on Immunoassays Expedite Clinical Decision-making

Immunoassays are among the most frequently performed tests in the laboratory and clinic. In past, cultures and serology were used for diagnosing infectious diseases. However, cultures take time to recover the virus or bacterium causing the infection. Moreover, certain microorganisms do not permit culturing in the laboratory. These issues have led to the development of [...]

9 12, 2014

Trends in Clinical Chemistry Testing

By |December 9th, 2014|Awareness Technology, Chemistry Analyzers|Comments Off on Trends in Clinical Chemistry Testing

The demand for diagnostic tests is increasing with an aging population, the need to identify emerging infections, detect chemical and biological threats, establish the presence of chronic and infectious diseases, and evaluate the quality of treatment provided for conditions such as diabetes, cardiac failure and cancer. The development of new diagnostic products has made it [...]

2 12, 2014

Ebola – ‘Promising’ Vaccine Offers New Hope

By |December 2nd, 2014|Ebola, Infectious Diseases|Comments Off on Ebola – ‘Promising’ Vaccine Offers New Hope

A new intramuscular vaccine has been developed at the US National Institute of Allergy and Infectious Diseases (NIAID) and Okairos, a biotechnology company acquired by GlaxoSmithKline. Following the first human trial of this experimental vaccine against Ebola virus disease (EVD), scientists at NIAID have described it as 'promising'. Their research was published in the New [...]

14 11, 2014

Studies Reveal Why Some People Survive Ebola

By |November 14th, 2014|Ebola, Infectious Diseases|Comments Off on Studies Reveal Why Some People Survive Ebola

Several experts have been looking into the question as to why some people survive Ebola and others don't. A study published last month based on the analysis of the first Ebola cases in Sierra Leone seems to provide some answers. The factors identified by this study are as follows: Pace at which the virus replicates [...]

7 11, 2014

Level-three Biosafety Laboratories in the Forefront of the Battle Against Ebola

By |November 7th, 2014|Ebola, Laboratory Equipment|Comments Off on Level-three Biosafety Laboratories in the Forefront of the Battle Against Ebola

Mali's first case of Ebola was a little girl who arrived in the country from Guinea. She was admitted to the pediatric ward of the Fousseyni Daou Hospital in Kayes on October 21 with visible symptoms of the dreaded virus. Her diagnosis took just a matter of hours in the level-three biosafety laboratory (BSL) set [...]

31 10, 2014

Optum Buying Alere Health for $600 Million

By |October 31st, 2014|Alere, Infectious Diseases|Comments Off on Optum Buying Alere Health for $600 Million

With dynamic shifts in the market, there has been a surge in integrated healthcare models. Optum, a unit of Minnesota-based UnitedHealth Group Inc., has made headlines with its decision to buy Alera Health in a $600 million all-cash transaction. Alere Health is a division of Alere Inc., a provider of rapid diagnostics for infectious disease, [...]